As representatives gather “In Solidarity for a Green World” at COP29 in Azerbaijan, we consider a few of the remarkable startups and spinouts from the University of Edinburgh working closer to home.
Biotechnology spinout Kynos Therapeutics has been acquired by clinical stage biopharmaceutical company Dr. Falk Pharma GmbH, which will develop Kynos’ KMO inflammation inhibitors for the treatment of acute pancreatitis.
An initiative that aims to significantly reduce carbon emissions from densely packed buildings in UK cities and towns has won a £4.5 million funding boost from UK Research and Innovation (UKRI).
A new spinout company has developed modular generator technology the founders say could reduce the levelized cost of energy for offshore renewables by 10 to 15 per cent.
Four University of Edinburgh projects have claimed victory at this year’s Converge Awards, an annual awards ceremony designed to celebrate and reward the pinnacle of Scottish academic innovation.
Biotech spinout Resolution Therapeutics has announced it has raised £63.5 million in a series B financing round led by healthcare investor Syncona Ltd.
No news categories with stories.
What’s your next challenge? Spin in, spin out or start up?
